Drugs & Targets FDA approves MI Cancer Seek as a CDx test for adults and pediatric patients November 08, 2024Vol.50 No.42
Conversation with The Cancer Letter Iowa’s Mark Burkard sees a role for data science in bringing clinical trials to rural clinicsThe state has the second highest (and rising) cancer rates in the U.S. November 01, 2024Vol.50 No.41By Paul Goldberg
Regulatory News At his 25-year “anniversary party,” Pazdur invites Califf and past FDA commissioners to talk about political interference November 01, 2024Vol.50 No.41By Claire Marie Porter
Regulatory News FDA extends shelf-life for IV fluids in shortage after Hurricane Helene November 01, 2024Vol.50 No.41By Claire Marie Porter
Trials & Tribulations Addressing high cancer mortality in Native Hawaiian and Pacific Islander populationsA call for equity in cancer research November 01, 2024Vol.50 No.41By Naoto T. Ueno
In Brief UChicago receives $75M from AbbVie Foundation for construction of the cancer care and research pavilion November 01, 2024Vol.50 No.41
In Brief Ruling changes NY law, restores oncologists ability to provide supportive therapies in-office November 01, 2024Vol.50 No.41
In Brief UF Health Cancer Center rolls out mobile cancer screening vehicle November 01, 2024Vol.50 No.41
In Brief UNM CCC receives three-year reaccreditation from the Commission on Cancer November 01, 2024Vol.50 No.41
